Toshiyuki Yoshio Selected Research

Warfarin (Coumadin)

9/2022	The effect of antithrombotic drug use on delayed bleeding with esophageal endoscopic resection.
11/2021	Rebleeding in patients with delayed bleeding after endoscopic submucosal dissection for early gastric cancer.
10/2021	Timing of bleeding and thromboembolism associated with endoscopic submucosal dissection for gastric cancer in Japan.
1/2021	Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study.
1/2021	Risk Factors for Bleeding After Endoscopic Submucosal Dissection for Gastric Cancer in Elderly Patients Older Than 80 Years in Japan.
1/2021	Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score.
9/2017	Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshiyuki Yoshio Research Topics

Disease

16	Neoplasms (Cancer) 11/2022 - 03/2007
13	Hemorrhage 01/2023 - 01/2013
11	Stomach Neoplasms (Stomach Cancer) 12/2023 - 05/2015
8	Esophageal Squamous Cell Carcinoma 04/2023 - 06/2017
4	Fistula 09/2023 - 01/2021
4	Thromboembolism 01/2023 - 01/2013
4	Esophageal Neoplasms (Esophageal Cancer) 11/2021 - 04/2016
3	Esophageal Stenosis (Esophageal Stricture) 04/2023 - 09/2015
3	Chronic Renal Insufficiency 10/2021 - 05/2015
3	Neoplasm Metastasis (Metastasis) 08/2018 - 07/2010
3	Ulcer 01/2018 - 05/2006
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 10/2021
2	Deglutition Disorders (Dysphagia) 01/2022 - 01/2022
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 05/2015
2	Rectal Neoplasms (Rectal Cancer) 01/2018 - 11/2011
2	Thrombosis (Thrombus) 12/2016 - 01/2013
2	Stomach Ulcer (Gastric Ulcer) 01/2008 - 05/2006
1	Esophageal Fistula 09/2023
1	Adenocarcinoma 07/2023
1	Gastritis 04/2023
1	Duodenal Obstruction 01/2023
1	Aneuploidy (Aneuploid) 11/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Anastomotic Leak 01/2021
1	Polyps 08/2020
1	Lobular Carcinoma 08/2018
1	Breast Neoplasms (Breast Cancer) 08/2018
1	Cicatrix (Scar) 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Infections 01/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2016
1	Atrial Fibrillation 12/2016
1	Barrett Esophagus (Barrett's Esophagus) 05/2016
1	Pneumonia (Pneumonitis) 09/2015
1	Mediastinal Emphysema (Pneumomediastinum) 09/2015
1	Diabetes Mellitus 02/2015
1	Splenomegaly 02/2012

Drug/Important Bio-Agent (IBA)

7	Warfarin (Coumadin)FDA LinkGeneric 09/2022 - 09/2017
7	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2022 - 05/2015
6	AnticoagulantsIBA 09/2022 - 12/2016
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 01/2021
3	Cilostazol (Pletal)FDA LinkGeneric 01/2023 - 01/2021
3	thienopyridineIBA 01/2023 - 10/2021
3	Heparin (Liquaemin)FDA LinkGeneric 09/2017 - 01/2013
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 10/2021
2	Purinergic P2Y Receptor AntagonistsIBA 01/2022 - 01/2021
2	Dabigatran FDA Link 01/2021 - 09/2017
2	Gemcitabine FDA Link 11/2011 - 08/2010
2	Acetic Acid (Vinegar)FDA LinkGeneric 01/2008 - 05/2006
1	Gastric MucinsIBA 07/2023
1	Hemostatics (Antihemorrhagics)IBA 04/2023
1	SteroidsIBA 04/2023
1	RNA (Ribonucleic Acid)IBA 11/2022
1	NucleotidesIBA 11/2022
1	BESIBA 01/2022
1	IodineIBA 11/2021
1	Menthol FDA Link 06/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2021
1	Factor Xa InhibitorsIBA 01/2021
1	Thrombin FDA Link 01/2021
1	Polyglycolic Acid (Polyglycolide)IBA 01/2021
1	Prostaglandins AIBA 01/2021
1	SolutionsIBA 01/2021
1	Capsules (Microcapsules)IBA 08/2020
1	Biomarkers (Surrogate Marker)IBA 09/2019
1	Dexmedetomidine FDA Link 01/2019
1	Midazolam (Versed)FDA LinkGeneric 01/2019
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2019
1	Nucleic AcidsIBA 01/2019
1	Rabeprazole (Aciphex)FDA Link 01/2018
1	Proton Pump InhibitorsIBA 01/2018
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2018
1	RivaroxabanIBA 09/2017
1	Penicillins (Penicillin)FDA Link 01/2017
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2016
1	AcidsIBA 05/2016
1	cyclo(Arg-Pro) (CI 4)IBA 09/2015

Therapy/Procedure

10	Therapeutics 12/2023 - 07/2010
8	Chemoradiotherapy 01/2022 - 04/2016
6	Drug Therapy (Chemotherapy) 08/2018 - 08/2007
4	Endoscopes 01/2022 - 12/2008
3	Self Expandable Metallic Stents 09/2023 - 01/2022
3	Stents 01/2023 - 01/2022
3	Gastrectomy 04/2022 - 12/2009
3	Neoadjuvant Therapy 01/2022 - 06/2017
3	Esophagectomy 12/2021 - 06/2017
3	Renal Dialysis (Hemodialysis) 10/2021 - 02/2015
3	Perioperative Period 01/2021 - 01/2013
2	Bridge Therapy 09/2017 - 12/2016
1	Palliative Care (Palliative Therapy) 09/2023
1	Radiotherapy 01/2022
1	Neck Dissection (Radical Neck Dissection) 03/2017
1	Argon Plasma Coagulation 01/2017
1	Drug-Eluting Stents 12/2016
1	Endoscopic Hemostasis 02/2015
1	Blood Transfusion (Blood Transfusions) 02/2015